c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
暂无分享,去创建一个
Eytan Domany | Avri Ben-Ze'ev | Amir Ben-Shmuel | Michal Sheffer | E. Domany | A. Ben-Ze'ev | A. Ben-Shmuel | Nancy Gavert | Michal Sheffer | Anna Shvab | Gal Haase | Eszter Bakos | N. Gavert | E. Bakos | A. Shvab | G. Haase | A. Ben-Ze’ev
[1] M. Mareel,et al. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. , 2002, Cancer research.
[2] B. Vanderhyden,et al. Lack of expression of c‐KIT in ovarian cancers is associated with poor prognosis , 2000, International journal of cancer.
[3] M. Toyota,et al. Expression and identification of aberrant c-kit transcripts in human cancer cells. , 1997, Cancer letters.
[4] A. Baldwin,et al. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. , 2006, Oncogene.
[5] Rainer Breitling,et al. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments , 2008, Bioinform..
[6] M. Caligiuri,et al. Sp1/NF κ B/HDAC/ miR-29b Regulatory Network in KIT-driven Myeloid Leukemia , 2010 .
[7] Eytan Domany,et al. Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes , 2010, BMC Bioinformatics.
[8] A. Ben-Ze'ev,et al. Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells , 2010, Journal of Cell Science.
[9] P. Altevogt,et al. L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.
[10] P. Einat,et al. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. , 2002, Genes & development.
[11] Avri Ben-Ze'ev,et al. The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.
[12] T. Hunter,et al. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility , 2000, Nature Genetics.
[13] Ramon Kranaster,et al. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro , 2011, Nucleic acids research.
[14] F. Lordick,et al. Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas , 2010, Langenbeck's Archives of Surgery.
[15] V. Sondak,et al. c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. , 2009, Histology and histopathology.
[16] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[17] Terry M. Therneau,et al. Faster cyclic loess: normalizing RNA arrays via linear models , 2004, Bioinform..
[18] M. Tainsky,et al. Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis , 1998, The EMBO journal.
[19] S. Lev,et al. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] T. Yeatman,et al. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. , 2002, Clinical colorectal cancer.
[21] A. Baldwin,et al. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.
[22] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[23] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[24] A. Ben-Ze'ev,et al. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression , 2013, Oncogene.
[25] U. Rodeck,et al. Growth stimulation of colorectal carcinoma cells via the c‐kit receptor is inhibited by TGF‐β1 , 1997 .
[26] S. Tsutsui,et al. A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer , 2006, British Journal of Cancer.
[27] S. Quake,et al. Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. , 2012, Gastroenterology.
[28] D. Nowak,et al. Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration. , 2011, European journal of pharmacology.
[29] M. Karin. Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.
[30] M. Nieto,et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.
[31] D. Radisky,et al. MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits , 2012, Nature Cell Biology.
[32] P. Polakis. The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.
[33] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[34] Johan Lennartsson,et al. Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.
[35] C. Sette,et al. Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients , 2004, International Journal of Colorectal Disease.
[36] D. Notterman,et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. , 2007, Cancer research.
[37] M. Caligiuri,et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. , 2010, Cancer cell.
[38] C. Sonnenschein,et al. Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats , 2008, Cancer Cell International.
[39] U. Rodeck,et al. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. , 2001, Cancer research.
[40] F. Da Settimo,et al. Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview. , 2011, Current medicinal chemistry.
[41] C. Unger,et al. c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis , 2010, Pathology & Oncology Research.
[42] N. S. Yee,et al. Differential roles of PI3‐kinase and Kit tyrosine 821 in Kit receptor‐mediated proliferation, survival and cell adhesion in mast cells. , 1995, The EMBO journal.
[43] M. Karin. Nuclear factor-κB in cancer development and progression , 2006, Nature.
[44] I. Roninson,et al. Regulation of Sp1 by cell cycle related proteins , 2008, Cell cycle.
[45] H. Kanzaki,et al. The expression of c-kit protein in human adult and fetal tissues. , 1993, Human Reproduction.
[46] Eytan Domany,et al. Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.